Call for Integrated Cervical Cancer Care for Women and Girls With HIV

On World Cervical Cancer Elimination Day, WHO is calling for stronger integration of HIV and cervical cancer services to ensure that women and girls living with HIV receive timely prevention, screening, diagnosis and treatment of cervical cancer. A coordinated person-centred approach can reduce deaths, improve health outcomes and contribute to an improved quality of life.

Women living with HIV have a disproportionate burden of cervical cancer, with a six-fold higher risk of developing cervical cancer than women without HIV. Women living with HIV can also experience poorer outcomes, including a higher risk of death 1–2 years after diagnosis and a three-fold greater likelihood of residual tumours following radiotherapy.

Despite these challenges, global progress to prevent and detect cervical cancer is accelerating. When women living with HIV are receiving antiretroviral therapy (ART) at the start of their cervical cancer treatment, mortality differences are no longer significant. Over 50% of girls in the WHO African Region, the region with the highest burden, received at least one dose of human papillomavirus (HPV) vaccine in 2025, and around 133 countries globally have introduced cervical cancer screening. The challenge is to ensure that these life-saving services reach every woman and girl, including those who are living with HIV.

WHO is actively engaged in this effort to ensure that women and girls living with HIV have access to high-quality cervical cancer prevention and care – including HPV vaccination and effective screening, diagnostic and treatment services. WHO is working closely with the International Agency for Research on Cancer (IARC) to develop a roadmap for the potential inclusion of HPV35 in future HPV vaccines, given the contribution of HPV35 to cervical cancer incidence and deaths, especially in the WHO African Region. WHO will also soon publish a technical policy brief that highlights the importance of rapid initiation or continuation of antiretroviral therapy (ART), multidisciplinary HIV and cancer care, monitoring for treatment toxicity and drug–drug interactions, support to complete cancer treatment, and access to palliative care when needed.

"Women living with HIV can benefit from well-established HIV services alongside expanding access to cervical cancer screening and treatment of precancerous lesions. We must build on this progress by linking HIV and cancer services more closely and strengthening the prevention and management of cervical cancer, so that every woman receives timely, coordinated and person-centred treatment and palliative care, if needed, to prevent avoidable suffering and deaths," said Dr Tereza Kasaeva, Director of the WHO Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections.

The path towards the global elimination of cervical cancer has been clearly articulated in WHO's Global strategy to accelerate the elimination of cervical cancer as a public health problem . The strategy defines interim 2030 targets of 90% coverage of HPV vaccination among girls by age 15 years, 70% coverage of screening with a high-performance test, and treatment and care for 90% of women identified with cervical cancer and cervical disease. The strategy describes the key actions across primary prevention, screening and treatment of precancerous lesions, management of invasive cancer and palliative care. Achieving these targets will require particular attention to women living with HIV, ensuring that they benefit fully and equitably from progress towards cervical cancer elimination.

"Reaching the 90-70-90 targets means reaching women at highest risk, including women living with HIV. HIV programmes provide a powerful platform for HPV screening and treatment of precancer because they reach women regularly over many years. And when cancer develops, HIV status must never become a barrier to timely diagnosis and treatment. No woman should face delays or gaps in cancer care because she is living with HIV," said Søren Brostrøm, Director WHO Department for Noncommunicable Diseases and Mental Health.

Leaving no woman behind

Eliminating cervical cancer is ultimately an equity commitment. Women and girls living with HIV, particularly those in settings where HIV prevalence is high and access to cancer diagnosis and treatment remains constrained, must be at the centre of that effort. Cervical cancer survivors and women living with HIV must also have a voice in shaping their care, helping to ensure that services respond to their needs and lived experience. The goal is clear: no woman or girl should be left behind in the effort to eliminate cervical cancer.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.